Albert C Ludolph Selected Research

Glioma (Gliomas)

1/2023	Bevacizumab is associated with cerebral microstructural alterations: a DTI study in high-grade glioma.
1/2018	Bevacizumab in temozolomide refractory high-grade gliomas: single-centre experience and review of the literature.
1/2017	Cerebral Microstructural Alterations after Radiation Therapy in High-Grade Glioma: A Diffusion Tensor Imaging-Based Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Albert C Ludolph Research Topics

Disease

104	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 05/2024 - 10/2002
26	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023 - 04/2007
22	Disease Progression 12/2023 - 08/2007
19	Parkinson Disease (Parkinson's Disease) 11/2022 - 09/2009
17	Alzheimer Disease (Alzheimer's Disease) 02/2024 - 06/2008
12	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 04/2024 - 10/2013
12	Multiple Sclerosis 02/2024 - 11/2009
12	Frontotemporal Dementia (Semantic Dementia) 11/2020 - 01/2004
10	Cognitive Dysfunction 01/2023 - 11/2013
9	Dementia (Dementias) 04/2022 - 08/2005
9	Motor Neuron Disease (Primary Lateral Sclerosis) 12/2019 - 12/2005
7	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2023 - 11/2011
6	Huntington Disease (Huntington's Disease) 01/2021 - 09/2007
6	Parkinsonian Disorders (Parkinsonism) 04/2015 - 08/2005
5	Neoplasms (Cancer) 01/2024 - 02/2012
5	Atrophy 01/2023 - 03/2003
5	Inflammation (Inflammations) 01/2023 - 01/2008
5	Respiratory Insufficiency (Respiratory Failure) 11/2022 - 07/2010
5	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2022 - 01/2012
4	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 12/2023 - 07/2010
4	Stroke (Strokes) 12/2022 - 03/2012
4	Epilepsy (Aura) 12/2022 - 06/2014
4	Gliosis 04/2022 - 11/2010
4	Synucleinopathies 01/2020 - 01/2015
4	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 10/2012
3	Nervous System Diseases (Neurological Disorders) 02/2024 - 01/2018
3	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 09/2023 - 09/2009
3	Glioma (Gliomas) 01/2023 - 01/2017
3	Deglutition Disorders (Dysphagia) 01/2022 - 01/2018
3	Body Weight (Weight, Body) 04/2016 - 12/2013
3	Multiple System Atrophy 01/2014 - 07/2010
2	Pneumonia (Pneumonitis) 12/2023 - 01/2016
2	Fatigue 11/2023 - 08/2003
2	Tension-Type Headache (Tension Headache) 09/2023 - 01/2023
2	Facial Paralysis (Facial Palsy) 09/2023 - 01/2023
2	Muscle Weakness 10/2022 - 01/2021
2	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2022 - 08/2014
2	Neuroinflammatory Diseases 12/2021 - 01/2020
2	Muscular Atrophy (Muscle Atrophy) 01/2021 - 01/2019
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2021 - 01/2015
2	Edema (Dropsy) 01/2021 - 04/2012
2	Hypercapnia 02/2019 - 07/2010
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 11/2018 - 11/2011
2	Fibrosis (Cirrhosis) 11/2018 - 01/2017
2	Cardiomyopathies (Cardiomyopathy) 11/2018 - 07/2011
2	Ischemic Stroke 12/2017 - 03/2012

Drug/Important Bio-Agent (IBA)

50	Biomarkers (Surrogate Marker)IBA 02/2024 - 03/2003
34	Proteins (Proteins, Gene)FDA Link 07/2023 - 12/2005
11	nusinersenIBA 04/2024 - 01/2018
10	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2022 - 09/2008
8	Riluzole FDA LinkGeneric 12/2023 - 09/2004
8	Antisense OligonucleotidesIBA 10/2023 - 01/2018
8	SynucleinsIBA 01/2022 - 01/2015
7	Glial Fibrillary Acidic ProteinIBA 02/2024 - 07/2010
6	Amyloid (Amyloid Fibrils)IBA 01/2023 - 06/2008
6	Dyneins (Dynein)IBA 04/2015 - 01/2009
5	Immunoglobulin G (IgG)IBA 09/2023 - 11/2009
5	tau Proteins (tau Protein)IBA 01/2023 - 12/2003
5	Superoxide Dismutase-1IBA 01/2022 - 05/2010
5	MicroRNAs (MicroRNA)IBA 01/2021 - 07/2013
4	RNA (Ribonucleic Acid)IBA 04/2023 - 03/2003
4	beta-SynucleinIBA 01/2023 - 01/2020
4	GadoliniumIBA 01/2021 - 04/2012
4	Peptides (Polypeptides)IBA 01/2021 - 05/2010
4	Dynactin ComplexIBA 04/2015 - 11/2005
4	Glutamic Acid (Glutamate)FDA Link 06/2014 - 03/2003
4	Amyloid beta-PeptidesIBA 01/2012 - 05/2010
3	AlbuminsIBA 05/2024 - 07/2010
3	rasagiline (Azilect)FDA Link 01/2024 - 01/2018
3	C-Reactive ProteinIBA 01/2024 - 01/2017
3	alpha-SynucleinIBA 11/2022 - 03/2016
3	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021 - 12/2002
3	Protein Isoforms (Isoforms)IBA 01/2020 - 05/2006
3	Retinaldehyde (Retinal)IBA 01/2020 - 01/2014
3	Phosphotransferases (Kinase)IBA 01/2020 - 01/2019
3	AntibodiesIBA 12/2018 - 10/2002
3	PrionsIBA 11/2017 - 12/2013
3	Levodopa (L Dopa)FDA LinkGeneric 01/2012 - 09/2009
3	ProteomeIBA 01/2010 - 11/2008
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2024 - 04/2017
2	SuspensionsIBA 12/2023 - 01/2021
2	tofersenIBA 12/2023 - 01/2022
2	LipidsIBA 06/2023 - 01/2023
2	Bevacizumab (Avastin)FDA Link 01/2023 - 01/2018
2	MMEIBA 10/2022 - 01/2016
2	Factor Xa InhibitorsIBA 06/2022 - 12/2017
2	chitotriosidaseIBA 01/2021 - 01/2018
2	SteroidsIBA 11/2019 - 12/2018
2	Oligoclonal BandsIBA 01/2019 - 08/2010
2	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 12/2018
2	Therapeutic UsesIBA 12/2018 - 01/2018
2	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 01/2018 - 09/2009
2	KinesinsIBA 01/2018 - 10/2014
2	ProgranulinsIBA 02/2017 - 01/2011
2	AdiponectinIBA 01/2017 - 04/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2016 - 01/2016

Therapy/Procedure

27	Therapeutics 01/2024 - 11/2008
4	Noninvasive Ventilation 03/2021 - 01/2018
3	Gastrostomy 12/2022 - 01/2015
2	Palliative Care (Palliative Therapy) 06/2023 - 02/2012